Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Executive Team
    • Board of Directors
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media
  • Training Videos

Press Releases

Nov 6, 2014

Aethlon Medical Announces Undetectable Ebola Virus in Patient Treated with Hemopurifier® Therapy

Oct 29, 2014

Aethlon Medical Discloses Ebola Treatment Pathways in the United States

Oct 14, 2014

Aethlon Medical Announces First Treatment of an Ebola Patient

Sep 26, 2014

Aethlon Medical and Exosome Sciences Announce Clinical Collaboration with Boston University CTE Center To Advance Diagnostic Candidate to Detect CTE in Former NFL Players

Sep 24, 2014

Aethlon Medical Announces Dengue Virus Treatment Agreement

Sep 22, 2014

Aethlon Medical Receives Notice of DARPA Contract Renewal

Sep 17, 2014

Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit

Sep 10, 2014

Aethlon Medical, Inc. Launches Digital Corporate Communication Channels

Sep 8, 2014

Aethlon Medical and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform

Sep 2, 2014

Aethlon Medical Announces Receipt of IRB Approval to Initiate Hemopurifier® Clinical Studies

    • 1...
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2023 Aethlon Medical, Inc. All Rights Reserved.